Search Results - "Caramelli, E."

Transdermal Testosterone Treatment in Women with Impaired Sexual Function after Oophorectomy by Shifren, Jan L, Braunstein, Glenn D, Simon, James A, Casson, Peter R, Buster, John E, Redmond, Geoffrey P, Burki, Regula E, Ginsburg, Elizabeth S, Rosen, Raymond C, Leiblum, Sandra R, Caramelli, Kim E, Jones, Kirtley P, Daugherty, Claire A, Mazer, Norman A

“…In premenopausal women, the rate of production of testosterone is about 300 μg (1040 nmol) per day, 1 of which about half is derived from the ovaries and half…”
Get full text

Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men by DOBS, A. S, MEIKLE, A. W, ARVER, S, SANDERS, S. W, CARAMELLI, K. E, MAZER, N. A

“…The pharmacokinetics, efficacy, and safety of the Androderm testosterone (T) transdermal system (TTD) and intramuscular T enanthate injections (i.m.) for the…”
Get full text

Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome by Sand, Peter K., MD, Davila, G. Willy, MD, Lucente, Vincent R., MD, MBA, Thomas, Heather, PhD, Caramelli, Kim E., MS, Hoel, Gary, PhD

“…Objective This subgroup analysis of a phase-3 study evaluated the efficacy and safety of oxybutynin chloride topical gel (OTG) in women with overactive bladder…”
Get full text

Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis by Lammers, K M, Ouburg, S, Morré, S A, Crusius, J B A, Gionchett, P, Rizzello, F, Morselli, C, Caramelli, E, Conte, R, Poggioli, G, Campieri, M, Peña, A S

“…To investigate the single nucleotide polymorphisms (SNPs) in genes involved in bacterial recognition and the susceptibility to pouchitis or pouchitis severity…”
Get full text

Effect of probiotic strains on interleukin 8 production by HT29/19A cells by Lammers, K.M, Helwig, U, Swennen, E, Rizzello, F, Venturi, A, Caramelli, E, Kamm, M.A, Brigidi, P, Gionchetti, P, Campieri, M

“…OBJECTIVES: Promising results from clinical studies on the effect of probiotics as maintenance therapy in inflammatory bowel disease and in the prevention of…”
Get full text

Maternal MTHFR variant forms increase the risk in offspring of isolated nonsyndromic cleft lip with or without cleft palate by Pezzetti, F., Martinelli, M., Scapoli, L., Carinci, F., Palmieri, A., Marchesini, J., Carinci, P., Caramelli, E., Rullo, R., Gombos, F., Tognon, M.

“…The pathogenesis of cleft lip with or without cleft palate (CL/P) is complex; its onset could be due to the interaction of various genetic and environmental…”
Get full text

Evidence of LEF1 fetal-maternal interaction in cleft lip with or without cleft palate in a consistent Italian sample study by Martinelli, M, Carinci, F, Morselli, P G, Caramelli, E, Palmieri, A, Girardi, A, Riberti, C, Scapoli, L

“…Epithelial mesenchymal transformation is considered a cardinal process in orofacial development. Several molecular players appear to be involved in this…”
Get more information

The MTHFD1 Gene is not Involved in Cleft Lip with or Without Palate Onset Among the Italian Population by Palmieri, A., Masiero, E., Martinelli, M., Scapoli, L., Pezzetti, F., Caramelli, E., Guidotti, L., Carinci, F.

“…Summary Nonsyndromic cleft lip with or without cleft palate (CL/P) is the most common orofacial malformation, having a non‐Mendelian and multifactorial…”
Get full text

Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system by DOBS, Adrian S, BACHORIK, Paul S, ARVER, Stefan, MEIKLE, A. Wayne, SANDERS, Steven W, CARAMELLI, Kim E, MAZER, Norman A

“…Serum lipoproteins and cardiovascular risk are affected by endogenous and exogenous sex hormones. As part of a multicenter evaluation of a permeation-enhanced…”
Get full text

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men by Arver, Stefan, Dobs, Adrian S., Meikle, A. Wayne, Caramelli, Kim E., Rajaram, Lakshminaryan, Sanders, Steven W., Mazer, Norman A.

“…OBJECTIVE An important aim in treating male hypogonadism is restoration of physiological concentrations of testosterone and its metabolites. We have assessed…”
Get full text

Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study by Staskin, David R, Dmochowski, Roger R, Sand, Peter K, Macdiarmid, Scott A, Caramelli, Kim E, Thomas, Heather, Hoel, Gary

“…We assessed the efficacy and safety of oxybutynin chloride topical gel vs placebo in adults with overactive bladder. Men and women 18 years or older with urge…”
Get more information

Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study by Nickel, J Curtis, O'Leary, Michael P, Lepor, Herbert, Caramelli, Kim E, Thomas, Heather, Hill, Lawrence A, Hoel, Gary E

“…We evaluated the efficacy and safety of 2 doses of silodosin vs placebo in men with moderate to severe abacterial chronic prostatitis/chronic pelvic pain…”
Get more information

Extracellular glycosaminoglycan changes in healthy and overgrown gingiva fibroblasts after cyclosporin A and cytokine treatments by Stabellini, G., Calastrini, C., Mariani, G., Gioia, M., Caramelli, E., Gagliano, N., Dellavia, C., Moscheni, C., Vizzotto, L., Calvi, E. M.

“…Background:  It has been demonstrated that cyclosporin A (CyA) blocks the immune system, acts on cytoskeleton and stimulates the production of extracellular…”
Get full text

FHIT oncosuppressor gene expression profile in human anal cancers by ZUCCHINI, C, CONCU, M, MARTIN, F, MORELLI, C, SALFI, N, CARINCI, P, TOGNON, M, CARAMELLI, E

“…The FHIT gene, a member of the histidine triad gene family, is a tumor suppressor gene exhibiting deletions in the majority of human cancers. Aberrant…”
Get full text

Ornithine decarboxylase, polyamines and CD11b expression in HL-60 cells during differentiation induced by retinoic acid by Stabellini, Giordano, Brugnoli, F, Calastrini, C, Vizzotto, L, Vertemati, M, Baroni, T, Caramelli, E, Marinucci, L, Pellati, A, Bertagnolo, V

“…Polyamines (PA) and retinoic acid affect mammalian cell growth, differentiation and apoptosis. Retinoic acid induces granulocytic differentiation of mieloid…”
Get full text

Effect of probiotic strains on interleukin 8 production by HT29 19A cells by Lammers, K M, Helwig, U, Swennen, E, Rizzello, F, Venturi, A, Caramelli, E, Kamm, M A, Brigidi, P, Gionchetti, P, Campieri, M

“…Promising results from clinical studies on the effect of probiotics as maintenance therapy in inflammatory bowel disease and in the prevention of onset of…”
Get full text

LACK OF MUTATIONS OF TYPE 1 11β-HYDROXYSTEROID DEHYDROGENASE GENE IN PATIENTS WITH ABDOMINAL OBESITY by Caramelli, Elisabetta, Strippoli, Pierluigi, Di Giacomi, Tiziana, Tietz, Catleen, Carinci, Paolo, Pasquali, Renato

“…There is increasing evidence that in human obesity, particularly the abdominal phenotype, the activity of the hypothalamic-pituitary-adrenal (HPA) axis is…”
Get full text

Correlation among amniotic fluid index (AFI), cesarean section rate, and labor length in inducted pregnancies beyond 41 weeks' gestation with unfavorable cervix by Rizzo, N, Farina, A, Santarsiero, G, Morano, D, Vitarelli, M, Caramelli, E, Carinci, P, Bovicelli, L

“…This paper evaluated how the pregnancy after 41 completed weeks' gestation with amniotic fluid index (AFI) > 6 has a slower response to the prostaglandin E2…”
Get more information

Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gel by Sand, Peter, MacDiarmid, Thomas, Caramelli, Hoel, Gary

“…Background: In a recent placebo-controlled Phase III study, oxybutynin chloride topical gel (OTG) significantly improved urinary continence in patients with…”
Get full text

Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gel by Sand, Peter K, Macdiarmid, Scott A, Thomas, Heather, Caramelli, Kim E, Hoel, Gary

“…In a recent placebo-controlled Phase III study, oxybutynin chloride topical gel (OTG) significantly improved urinary continence in patients with overactive…”
Get full text